|
Video: What is a Stock Split?
|
|
PAVmed is a medical technology company organized to advance a pipeline of medical technologies from concept to commercialization. Co.'s EsoGuard and EsoCheck have been developed to provide a screening test for the early detection of adenocarcinoma of the esophagus (EAC) and Barrett's Esophagus (BE), including dysplastic BE and related pre-cursors to EAC in patients with chronic gastroesophageal reflux. Co.'s EsoCure is in development as an Esophageal Ablation Device, with the intent to allow a clinician to treat dysplastic BE before it can progress to EAC, a lethal esophageal cancer. Co.'s CarpX is a minimally invasive surgical device for use in the treatment of carpal tunnel syndrome. According to our PAVM split history records, Pavmed has had 1 split. | |
|
Pavmed (PAVM) has 1 split in our PAVM split history database. The split for PAVM took place on December 07, 2023. This was a 1 for 15 reverse split, meaning for each 15 shares of PAVM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as Pavmed conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the PAVM split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Pavmed shares, starting with a $10,000 purchase of PAVM, presented on a split-history-adjusted basis factoring in the complete PAVM split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/28/2016 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$195.00 |
|
End price/share: |
$2.73 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.60% |
|
Average Annual Total Return: |
-42.69% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$139.96 |
|
Years: |
7.67 |
|
|
|
Date |
Ratio |
12/07/2023 | 1 for 15 |
|
|